Shortening the long-COVID: An exploratory review on the potential of Unani medicines in mitigating post-Covid-19 sequelae
Background: Since the early days of the coronavirus disease-2019 (COVID-19) pandemic, a number of persistent symptoms have been observed in the patients, continuing for weeks or even months after recovery, now named as post-COVID-19 condition, or long-COVID. The commonest symptoms are neurological (...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-05-01
|
Series: | Phytomedicine Plus |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667031324000459 |